Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study

Henriette Thisted Horsdal; Flemming Søndergaard; Søren Paaske Johnsen; Jørgen Rungby

doi:10.1002/pds.2097

Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study

Henriette Thisted Horsdal, Flemming Søndergaard, Søren Paaske Johnsen, Jørgen Rungby

Endokrinologisk Afd. I

Abstrakt

Data on cardiovascular risk associated with different types of antidiabetic treatments are sparse and conflicting. We examined the risk of hospitalisation with myocardial infarction (MI) among patients treated with sulfonylureas, metformin, insulin, any combination and no antidiabetic pharmacotherapy.

Originalsprog	Engelsk
Tidsskrift	Pharmacoepidemiology and Drug Safety
Vol/bind	20
Udgave nummer	4
Sider (fra-til)	331-337
Antal sider	7
ISSN	1053-8569
DOI	https://doi.org/10.1002/pds.2097
Status	Udgivet - 1 apr. 2011

Adgang til dokumentet

10.1002/pds.2097

Citationsformater

@article{516e73903dec4549824b8d65aef1f68a,

title = "Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study",

abstract = "Data on cardiovascular risk associated with different types of antidiabetic treatments are sparse and conflicting. We examined the risk of hospitalisation with myocardial infarction (MI) among patients treated with sulfonylureas, metformin, insulin, any combination and no antidiabetic pharmacotherapy.",

author = "Horsdal, {Henriette Thisted} and Flemming S{\o}ndergaard and Johnsen, {S{\o}ren Paaske} and J{\o}rgen Rungby",

note = "Copyright {\textcopyright} 2011 John Wiley & Sons, Ltd.",

year = "2011",

month = apr,

day = "1",

doi = "10.1002/pds.2097",

language = "English",

volume = "20",

pages = "331--337",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "John/Wiley & Sons Ltd",

number = "4",

}

TY - JOUR

T1 - Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study

AU - Horsdal, Henriette Thisted

AU - Søndergaard, Flemming

AU - Johnsen, Søren Paaske

AU - Rungby, Jørgen

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Data on cardiovascular risk associated with different types of antidiabetic treatments are sparse and conflicting. We examined the risk of hospitalisation with myocardial infarction (MI) among patients treated with sulfonylureas, metformin, insulin, any combination and no antidiabetic pharmacotherapy.

AB - Data on cardiovascular risk associated with different types of antidiabetic treatments are sparse and conflicting. We examined the risk of hospitalisation with myocardial infarction (MI) among patients treated with sulfonylureas, metformin, insulin, any combination and no antidiabetic pharmacotherapy.

U2 - 10.1002/pds.2097

DO - 10.1002/pds.2097

M3 - Journal article

VL - 20

SP - 331

EP - 337

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

SN - 1053-8569

IS - 4

ER -

Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study

Abstrakt

Adgang til dokumentet

Fingeraftryk

Citationsformater